MRC Confidence in concepts. VEGFC treatment to protect from diabetic nephropathy in type 1 diabetes: a translational approach

Foster, R R (Recipient)

Bristol Medical School (THS)

Prize: Other distinction

Description

1yr project using experimental models of type 1 diabetes to show proof of principle for VEGFC treatment. This will be to secure major investment from Syncona to translate to patients

Awarded date	12 Feb 2020
Degree of recognition	Local
Granting Organisations	Medical Research Council

MRC Confidence in concepts. VEGFC treatment to protect from diabetic nephropathy in type 1 diabetes: a translational approach

Description

Fingerprint

Related content

Research Outputs

VEGFC reduces glomerular albumin permeability and protects against alterations in VEGF receptor expression in diabetic nephropathy

Activities

Intermediate Basic Science Research Fellowship - Can VEGF-C regulate VEGF-A induced changes in glomerular endothelial cell barrier properties in health and disease?